NEW YORK (GenomeWeb News) – NanoString Technologies has priced the follow-on public offering of its common stock at $18.50 per share.

The company announced the $55 million offering last week and launched it earlier this week. The bookrunning managers are JP Morgan and Morgan Stanley. The co-managers are Leerink Partners and RW Baird. NanoString has given the underwriters a 30-day option to purchase an additional $8.25 million of its common shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.